Emmessar Biotech & Nutrition Ltd.

View in App
26.58 +0.24 ▲0.9%

11 December 2023, 04:01:00 PM
Volume: 4,871

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ebnl.org
Market Cap 13.28 Cr.
Enterprise Value(EV) 7.44 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.85 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 31.32 Trailing Twelve Months Ending 2023-09
Industry PE 38.33 Trailing Twelve Months Ending 2023-09
Book Value / Share 13.85 Trailing Twelve Months Ending 2023-09
Price to Book Value 1.92 Calculated using Price: 26.58
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.50 Cr. 4,996,100 Shares
FaceValue 10
About Emmessar Biotech & Nutrition Ltd.
Emmessar Biotech & Nutrition Ltd., was originally started as Emmessar Chemical Industries Ltd on March 17,1992, for manufacturing Super Speciality Fine Chemicals. The Company succeeded in developing many Speciality Fine Chemicals in its own In-house R&D, which was recognised on January 15, 1996 by DSIR, Ministry of Science & Technology, Government of India, New Delhi .

Emmessar Biotech & Nutrition Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Emmessar Biotech & Nutrition Ltd. Performance

View details >>
1 Day
+0.91%
1 Week
+3.38%
1 Month
+9.56%
3 Month
+5.14%
6 Month
+13.06%
1 Year
-13.98%
2 Year
-1.01%
5 Year
+55.89%
10 Year
+777.23%

Emmessar Biotech & Nutrition Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -7.98 -40.75 78.73 36.00 16.42 19.40 29.10 8.01 7.85
Return on Capital Employed (%) -10.49 -59.37 79.46 31.46 9.00 18.87 45.29 15.71 14.99
Return on Assets (%) -5.08 -20.32 44.83 26.93 12.75 14.93 22.47 6.30 6.42

Emmessar Biotech & Nutrition Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 1 1 2 3 4 4 6 6 7 7
Non Curr. Liab. 0 1 1 0 0 0 0 1 1
Curr. Liab. 1 1 0 0 1 1 2 1 1 0
Minority Int.
Equity & Liab. 2 2 3 4 5 5 7 8 8 8
Non Curr. Assets 2 1 2 2 2 2 2 2 2 2
Curr. Assets 1 1 1 1 3 3 6 6 6 6
Misc. Exp. not W/O
Total Assets 2 2 3 4 5 5 7 8 8 8

Emmessar Biotech & Nutrition Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 2 2 3 1 1 3 7 0 1 1
Other Income 0 0 1 1 1 1 1 2 2 2
Total Income 2 2 4 3 2 5 8 2 3 3
Total Expenditure -2 -2 -2 -2 -1 -4 -6 -1 -2 -2
PBIDT 0 0 1 1 1 1 2 1 1 1
Interest 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 -1 0 0 -1
Exceptional Items -1 0 0
PAT 0 0 1 1 1 1 1 0 1 0
Adjusted EPS 0 -1 2 2 1 2 3 1 1 1

Emmessar Biotech & Nutrition Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 1 1 0 1 0 2 0
Cash Fr. Inv. 0 -1 -1 0 -1 0 -3 -1
Cash Fr. Finan.
Net Change 0 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 1 0 0

Emmessar Biotech & Nutrition Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 58.50 58.50 58.51 58.19 56.31 58.53 59.08 58.19 59.53
Public 41.50 41.50 41.49 41.81 43.69 41.47 40.92 41.81 40.47
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Emmessar Biotech & Nutrition Ltd. Announcements

View details >>
Sat, 09 Dec 2023
Board Meeting Outcome for Outcome Of Board Meeting
The Board of Directors at their meeting today approved and took on record the Un-Audited Financial Results for the second quarter ended September 30 2023
Tue, 28 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to the provisions of Reg 30 & 47 of SEBI(LODR) Regulations 2015 the newspaper clippings regarding the intimation of Board Meeting to be held on Saturday December 09 2023 at 12 Noon published in the Free Press Journal & Nav Shakti dt 28-11-2023 are attached.
Mon, 27 Nov 2023
Board Meeting Intimation for For Un-Audited Quarterly Result For September 30 2023
EMMESSAR BIOTECH & NUTRITION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/12/2023 inter alia to consider and approve Pursuant to Reg. 29 & 33 of SEBI (LODR) Regulations 2015 a meeting of Board of Directors will be held on Saturday December 09 2023 at 12 Noon to consider & Approve the Un-Audited Financial Result for the Quarter Ended September 30 2023.

Emmessar Biotech & Nutrition Ltd. Technical Scans

View details >>
Mon, 11 Dec 2023
High Delivery Percentage High Delivery Percentage
Opening at Low Opening at Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
Opening at Low for 2 Days Opening at Low for 2 Days
CCI Crossed Above 100 CCI Crossed Above 100

Emmessar Biotech & Nutrition Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 296,485.82 1,235.70 +0.0%
Divi's Laboratories Ltd. 97,380.51 3,668.25 -0.4%
Cipla Ltd. 97,091.96 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. 91,293.11 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. 79,724.28 5,544.70 -0.1%
Mankind Pharma Ltd. 76,862.91 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. 70,227.43 2,075.00 +1.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.68 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-09 73.12 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-09 28.12 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 17.93 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.30 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 59.96 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.64 2,075.00 +1.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.96 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-09 7.68 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-09 3.91 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.58 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.26 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 9.12 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.47 2,075.00 +1.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,075.00 +1.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,075.00 +1.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,075.00 +1.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,075.00 +1.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,075.00 +1.0%

Emmessar Biotech & Nutrition Ltd. FAQ's

What is Emmessar Biotech&Nut share price?
Can I buy Emmessar Biotech&Nut shares now?
What is the Market Cap of Emmessar Biotech&Nut?
What are the key metrics to analyse Emmessar Biotech&Nut?
What is the 52 Week High and Low of Emmessar Biotech&Nut?
What is the trend of Emmessar Biotech&Nut share price?